Pretreatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy.

Kamimura, Mikio; Taguchi, Akira; Nakamura, Yukio; Koiwai, Hidefumi; Ikegami, Shota; Uchiyama, Shigeharu; Kato, Hiroyuki

Kamimura, Mikio; Taguchi, Akira; Nakamura, Yukio; Koiwai, Hidefumi; Ikegami, Shota; Uchiyama, Shigeharu; Kato, Hiroyuki.

Afiliación

Kamimura M; Center for Osteoporosis and Spinal Disorders, Kamimura Orthopedic Clinic, Matsumoto, Japan.
Taguchi A; Department of Oral and Maxillofacial Radiology, Matsumoto Dental University, Shiojiri, Japan.
Nakamura Y; Department of Orthopaedic Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Koiwai H; Department of Orthopedic Surgery, Showa-Inan General Hospital, Komagane, Japan.
Ikegami S; Koiwai Orthopedic Clinic, Komoro, Japan.
Uchiyama S; Department of Orthopaedic Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Kato H; Department of Orthopaedic Surgery, Shinshu University School of Medicine, Matsumoto, Japan.

Ther Clin Risk Manag ; 14: 637-642, 2018.

Article en En | MEDLINE | ID: mdl-29662314

Palabras clave

bone mineral density; cancelleous bones; cortical bone; daily teriparatide; denosumab; osteoporosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Ther Clin Risk Manag Año: 2018 Tipo del documento: Article País de afiliación: Japón